Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087304939> ?p ?o ?g. }
- W3087304939 endingPage "11881" @default.
- W3087304939 startingPage "11854" @default.
- W3087304939 abstract "The growth of uterine fibroids is sex hormone-dependent and commonly associated with highly incapacitating symptoms. Most treatment options consist of the control of these hormonal effects, ultimately blocking proliferative estrogen signaling (i.e., oral contraceptives/antagonization of human gonadotropin-releasing hormone receptor [hGnRH-R] activity). Full hGnRH-R blockade, however, results in menopausal symptoms and affects bone mineralization, thus limiting treatment duration or demanding estrogen add-back approaches. To overcome such issues, we aimed to identify novel, small-molecule hGnRH-R antagonists. This led to the discovery of compound BAY 1214784, an orally available, potent, and selective hGnRH-R antagonist. Altering the geminal dimethylindoline core of the initial hit compound to a spiroindoline system significantly improved GnRH-R antagonist potencies across several species, mandatory for a successful compound optimization in vivo. In a first-in-human study in postmenopausal women, once daily treatment with BAY 1214784 effectively lowered plasma luteinizing hormone levels by up to 49%, at the same time being associated with low pharmacokinetic variability and good tolerability." @default.
- W3087304939 created "2020-09-25" @default.
- W3087304939 creator A5008439399 @default.
- W3087304939 creator A5012983887 @default.
- W3087304939 creator A5015300999 @default.
- W3087304939 creator A5021012893 @default.
- W3087304939 creator A5024672014 @default.
- W3087304939 creator A5027786333 @default.
- W3087304939 creator A5030290228 @default.
- W3087304939 creator A5032333549 @default.
- W3087304939 creator A5032359621 @default.
- W3087304939 creator A5038885061 @default.
- W3087304939 creator A5040786897 @default.
- W3087304939 creator A5049085425 @default.
- W3087304939 creator A5049261308 @default.
- W3087304939 creator A5062949066 @default.
- W3087304939 creator A5068995047 @default.
- W3087304939 creator A5086461008 @default.
- W3087304939 creator A5088066412 @default.
- W3087304939 date "2020-09-22" @default.
- W3087304939 modified "2023-10-01" @default.
- W3087304939 title "Discovery and Characterization of BAY 1214784, an Orally Available Spiroindoline Derivative Acting as a Potent and Selective Antagonist of the Human Gonadotropin-Releasing Hormone Receptor as Proven in a First-In-Human Study in Postmenopausal Women" @default.
- W3087304939 cites W1027059434 @default.
- W3087304939 cites W1481726822 @default.
- W3087304939 cites W1516646538 @default.
- W3087304939 cites W1572108318 @default.
- W3087304939 cites W1587498640 @default.
- W3087304939 cites W1957585951 @default.
- W3087304939 cites W1969360633 @default.
- W3087304939 cites W1970566094 @default.
- W3087304939 cites W1973461107 @default.
- W3087304939 cites W1977941515 @default.
- W3087304939 cites W1984937884 @default.
- W3087304939 cites W1999248363 @default.
- W3087304939 cites W2005517577 @default.
- W3087304939 cites W2009667219 @default.
- W3087304939 cites W2016408686 @default.
- W3087304939 cites W2016927496 @default.
- W3087304939 cites W2018729486 @default.
- W3087304939 cites W2026209290 @default.
- W3087304939 cites W2036271385 @default.
- W3087304939 cites W2050975214 @default.
- W3087304939 cites W2056455169 @default.
- W3087304939 cites W2059008956 @default.
- W3087304939 cites W2059664977 @default.
- W3087304939 cites W2074631079 @default.
- W3087304939 cites W2083105811 @default.
- W3087304939 cites W2085048839 @default.
- W3087304939 cites W2085320423 @default.
- W3087304939 cites W2107163131 @default.
- W3087304939 cites W2110478240 @default.
- W3087304939 cites W2113600008 @default.
- W3087304939 cites W2118330723 @default.
- W3087304939 cites W2118482528 @default.
- W3087304939 cites W2120483146 @default.
- W3087304939 cites W2141410012 @default.
- W3087304939 cites W2145430095 @default.
- W3087304939 cites W2149141089 @default.
- W3087304939 cites W2161897582 @default.
- W3087304939 cites W2165449530 @default.
- W3087304939 cites W2166032823 @default.
- W3087304939 cites W2171360281 @default.
- W3087304939 cites W2180221738 @default.
- W3087304939 cites W2182036929 @default.
- W3087304939 cites W2208422277 @default.
- W3087304939 cites W2272145904 @default.
- W3087304939 cites W2290547251 @default.
- W3087304939 cites W2293749716 @default.
- W3087304939 cites W2482610020 @default.
- W3087304939 cites W2546589842 @default.
- W3087304939 cites W2591766847 @default.
- W3087304939 cites W2595206985 @default.
- W3087304939 cites W2602082991 @default.
- W3087304939 cites W2617465248 @default.
- W3087304939 cites W2756965977 @default.
- W3087304939 cites W2760367307 @default.
- W3087304939 cites W2765174790 @default.
- W3087304939 cites W2765403974 @default.
- W3087304939 cites W2765546885 @default.
- W3087304939 cites W2771867387 @default.
- W3087304939 cites W2774333028 @default.
- W3087304939 cites W2791967997 @default.
- W3087304939 cites W2884469905 @default.
- W3087304939 cites W2923112225 @default.
- W3087304939 cites W2951922048 @default.
- W3087304939 cites W2969537575 @default.
- W3087304939 cites W2978453381 @default.
- W3087304939 cites W2990363083 @default.
- W3087304939 cites W3008541467 @default.
- W3087304939 cites W3011843929 @default.
- W3087304939 cites W4210998728 @default.
- W3087304939 doi "https://doi.org/10.1021/acs.jmedchem.0c01076" @default.
- W3087304939 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32960053" @default.
- W3087304939 hasPublicationYear "2020" @default.
- W3087304939 type Work @default.
- W3087304939 sameAs 3087304939 @default.
- W3087304939 citedByCount "11" @default.
- W3087304939 countsByYear W30873049392020 @default.